Multiple Myeloma — Trials

Multiple Myeloma — Trials · CancerIndex

Clinical trials

Registered studies

3,384 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 814
Recruiting: 414
Ph III recruiting: 54
Growth YoY: +13.3%
Industry share: 29%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.1%
Trials / 1,000 deaths: 70.3 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (537)

clinicaltrialsPublishedShowing 51–100 of 124 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04629430	Effects of Prebiotics on Gut Microbiome in Patients Undergoing HSCT(HCTDiet)	completed	N/A	40	University of VirginiaOTHER	1	Jan 4, 2023	clinicaltrials
NCT02158052	Combined Bone Marrow and Renal Transplantation for Hematologic Disorders With End Stage Renal Disease	completed	N/A	2	Massachusetts General HospitalOTHER	1	Dec 13, 2022	clinicaltrials